pubmed-article:19649631 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:19649631 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:19649631 | lifeskim:mentions | umls-concept:C0206686 | lld:lifeskim |
pubmed-article:19649631 | lifeskim:mentions | umls-concept:C0031327 | lld:lifeskim |
pubmed-article:19649631 | lifeskim:mentions | umls-concept:C0003250 | lld:lifeskim |
pubmed-article:19649631 | lifeskim:mentions | umls-concept:C0036043 | lld:lifeskim |
pubmed-article:19649631 | lifeskim:mentions | umls-concept:C2713009 | lld:lifeskim |
pubmed-article:19649631 | lifeskim:mentions | umls-concept:C0205269 | lld:lifeskim |
pubmed-article:19649631 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:19649631 | pubmed:dateCreated | 2010-1-20 | lld:pubmed |
pubmed-article:19649631 | pubmed:abstractText | Insulin-like growth factor 1 receptor signaling through upregulation of the stimulatory ligand IGF-II has been implicated in the pathogenesis of adrenocortical carcinoma. As there is a paucity of effective therapies, this dose expansion cohort of a phase 1 study was undertaken to determine the safety, tolerability, pharmacokinetics, and effects on endocrine markers of figitumumab in patients with adrenocortical carcinoma. | lld:pubmed |
pubmed-article:19649631 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19649631 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19649631 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19649631 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19649631 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19649631 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19649631 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19649631 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19649631 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19649631 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19649631 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19649631 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19649631 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19649631 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19649631 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19649631 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19649631 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19649631 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19649631 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19649631 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19649631 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19649631 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19649631 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19649631 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19649631 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19649631 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19649631 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19649631 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19649631 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19649631 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19649631 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19649631 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19649631 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19649631 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19649631 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19649631 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19649631 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19649631 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19649631 | pubmed:language | eng | lld:pubmed |
pubmed-article:19649631 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19649631 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:19649631 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19649631 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19649631 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19649631 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19649631 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:19649631 | pubmed:month | Mar | lld:pubmed |
pubmed-article:19649631 | pubmed:issn | 1432-0843 | lld:pubmed |
pubmed-article:19649631 | pubmed:author | pubmed-author:de... | lld:pubmed |
pubmed-article:19649631 | pubmed:author | pubmed-author:HammerGary... | lld:pubmed |
pubmed-article:19649631 | pubmed:author | pubmed-author:YinDonghuaD | lld:pubmed |
pubmed-article:19649631 | pubmed:author | pubmed-author:GualbertoAnto... | lld:pubmed |
pubmed-article:19649631 | pubmed:author | pubmed-author:WordenFrankF | lld:pubmed |
pubmed-article:19649631 | pubmed:author | pubmed-author:HaluskaPaulP | lld:pubmed |
pubmed-article:19649631 | pubmed:author | pubmed-author:OlmosDavidD | lld:pubmed |
pubmed-article:19649631 | pubmed:author | pubmed-author:BatzelGretche... | lld:pubmed |
pubmed-article:19649631 | pubmed:author | pubmed-author:PaccagnellaM... | lld:pubmed |
pubmed-article:19649631 | pubmed:author | pubmed-author:SchteingartDa... | lld:pubmed |
pubmed-article:19649631 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:19649631 | pubmed:volume | 65 | lld:pubmed |
pubmed-article:19649631 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:19649631 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:19649631 | pubmed:pagination | 765-73 | lld:pubmed |
pubmed-article:19649631 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
pubmed-article:19649631 | pubmed:meshHeading | pubmed-meshheading:19649631... | lld:pubmed |
pubmed-article:19649631 | pubmed:meshHeading | pubmed-meshheading:19649631... | lld:pubmed |
pubmed-article:19649631 | pubmed:meshHeading | pubmed-meshheading:19649631... | lld:pubmed |
pubmed-article:19649631 | pubmed:meshHeading | pubmed-meshheading:19649631... | lld:pubmed |
pubmed-article:19649631 | pubmed:meshHeading | pubmed-meshheading:19649631... | lld:pubmed |
pubmed-article:19649631 | pubmed:meshHeading | pubmed-meshheading:19649631... | lld:pubmed |
pubmed-article:19649631 | pubmed:meshHeading | pubmed-meshheading:19649631... | lld:pubmed |
pubmed-article:19649631 | pubmed:meshHeading | pubmed-meshheading:19649631... | lld:pubmed |
pubmed-article:19649631 | pubmed:meshHeading | pubmed-meshheading:19649631... | lld:pubmed |
pubmed-article:19649631 | pubmed:meshHeading | pubmed-meshheading:19649631... | lld:pubmed |
pubmed-article:19649631 | pubmed:meshHeading | pubmed-meshheading:19649631... | lld:pubmed |
pubmed-article:19649631 | pubmed:meshHeading | pubmed-meshheading:19649631... | lld:pubmed |
pubmed-article:19649631 | pubmed:meshHeading | pubmed-meshheading:19649631... | lld:pubmed |
pubmed-article:19649631 | pubmed:meshHeading | pubmed-meshheading:19649631... | lld:pubmed |
pubmed-article:19649631 | pubmed:meshHeading | pubmed-meshheading:19649631... | lld:pubmed |
pubmed-article:19649631 | pubmed:meshHeading | pubmed-meshheading:19649631... | lld:pubmed |
pubmed-article:19649631 | pubmed:meshHeading | pubmed-meshheading:19649631... | lld:pubmed |
pubmed-article:19649631 | pubmed:meshHeading | pubmed-meshheading:19649631... | lld:pubmed |
pubmed-article:19649631 | pubmed:meshHeading | pubmed-meshheading:19649631... | lld:pubmed |
pubmed-article:19649631 | pubmed:meshHeading | pubmed-meshheading:19649631... | lld:pubmed |
pubmed-article:19649631 | pubmed:meshHeading | pubmed-meshheading:19649631... | lld:pubmed |
pubmed-article:19649631 | pubmed:meshHeading | pubmed-meshheading:19649631... | lld:pubmed |
pubmed-article:19649631 | pubmed:meshHeading | pubmed-meshheading:19649631... | lld:pubmed |
pubmed-article:19649631 | pubmed:year | 2010 | lld:pubmed |
pubmed-article:19649631 | pubmed:articleTitle | Safety, tolerability, and pharmacokinetics of the anti-IGF-1R monoclonal antibody figitumumab in patients with refractory adrenocortical carcinoma. | lld:pubmed |